Reldesemtiv
- Generic Name
- Reldesemtiv
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18F2N6O
- CAS Number
- 1345410-31-2
- Unique Ingredient Identifier
- 4S0HBYW6QE
- Background
Reldesemtiv is under investigation in clinical trial NCT03160898 (A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath